Quantitative role of COMT in dopamine clearance in the prefrontal cortex of freely moving mice

Journal of Neurochemistry
Mikko KäenmäkiP T Männistö

Abstract

Catechol-O-methyltransferase (COMT) plays an active role in the metabolism of dopamine (DA) in the prefrontal cortex (PFC). Because of low levels of dopamine transporter (DAT), it is proposed that the majority of released DA is taken up by either norepinephrine transporter (NET) and subsequently metabolized by monoamine oxidize (MAO) or by uptake(2) (to glial cells and post-synaptic neurons) and metabolized by COMT. However, a comprehensive in vivo study of rating the mechanisms involved in DA clearance in the PFC has not been done. Here, we employ two types of microdialysis to study these pathways using DAT, NET and MAO blockers in conscious mice, with or without Comt gene disruption. In quantitative no-net-flux microdialysis, DA levels were increased by 60% in the PFC of COMT-knockout (ko) mice, but not in the striatum and nucleus accumbens. In conventional microdialysis studies, we showed that selective NET and MAO inhibition increased DA levels in the PFC of wild-type mice by two- to fourfold, an effect that was still doubled in COMT-ko mice. Inhibition of DAT had no effect on DA levels in either genotype. Therefore, we conclude that in the mouse, PFC COMT contributes about one half of the total DA clearance.

References

Oct 1, 1977·Neuropharmacology·R Weinshilboum, F Raymond
Apr 1, 1991·DNA and Cell Biology·K LundströmI Ulmanen
Oct 1, 1990·Clinical Pharmacology and Therapeutics·B BoudíkováR Weinshilboum
Apr 1, 1988·Naunyn-Schmiedeberg's Archives of Pharmacology·V G WilsonU Trendelenburg
Jul 1, 1993·Journal of Neuroscience Methods·J B Justice
Dec 1, 1995·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·T KarhunenP Panula
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·M KarayiorgouJ A Gogos
Jul 2, 1998·Journal of Neurochemistry·B K Yamamoto, S Novotney
Aug 26, 1998·Proceedings of the National Academy of Sciences of the United States of America·J A GogosM Karayiorgou
Jun 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·M F EganD R Weinberger
Oct 12, 2001·Journal of Neurochemistry·M L MundorfR M Wightman
Feb 19, 2002·The European Journal of Neuroscience·Marko HuotariPekka T Männistö
Jul 3, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Michelle E Page, Irwin Lucki
Aug 22, 2002·BMC Physiology·Cecilia OdlindPeter Hansell
Nov 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Marko HuotariPekka T Männistö
Jul 29, 2003·Journal of Applied Toxicology : JAT·Kristiina HaasioPekka T Männistö
Oct 24, 2003·Psychopharmacology·Marko HuotariPekka T Männistö
Jun 11, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·E M TunbridgeP J Harrison
Jul 1, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Hao-Wei ShenIchiro Sora
Aug 20, 2004·Pharmacological Reviews·Graeme EisenhoferDavid S Goldstein
Sep 21, 2004·Naunyn-Schmiedeberg's Archives of Pharmacology·Markus M ForsbergPekka T Männistö

❮ Previous
Next ❯

Citations

Feb 22, 2012·Psychopharmacology·Christopher T Smith, Charlotte A Boettiger
Nov 22, 2012·Proceedings of the National Academy of Sciences of the United States of America·Francesco PapaleoDaniel R Weinberger
Jun 23, 2012·Pharmacogenetics and Genomics·Anne Tammimäki, Pekka T Männistö
Apr 13, 2011·Journal of Psychiatry & Neuroscience : JPN·Cecilia Flores
Aug 3, 2013·Molecular Neurobiology·Hongjuan SunJing Wu
Jan 31, 2014·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Young Ho Lee, Gwan Gyu Song
Nov 19, 2014·Der Nervenarzt·G Gründer, T Bartsch
Dec 10, 2015·Cortex; a Journal Devoted to the Study of the Nervous System and Behavior·Jessica L IhneAdam E Green
Oct 2, 2012·European Journal of Pharmacology·Rodolfo BongiovanniGeorge E Jaskiw
Apr 30, 2011·Neuroscience and Biobehavioral Reviews·Zsofia NemodaMaria Sasvari-Szekely
Aug 20, 2011·Basic & Clinical Pharmacology & Toxicology·Nadia SchendzielorzAtso Raasmaja
Jan 11, 2011·European Journal of Pain : EJP·Oleg KamburVesa K Kontinen
Jun 21, 2012·Bipolar Disorders·Márcio Gerhardt Soeiro-de-SouzaRicardo Alberto Moreno
Jun 8, 2011·Journal of Neurochemistry·Vincent Leviel
Feb 11, 2012·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Philip Asherson, Thomas S Price
Sep 27, 2014·Alcoholism, Clinical and Experimental Research·Aqilah M McCaneChristopher C Lapish
Oct 21, 2015·Frontiers in Human Neuroscience·Katharina SchmackPhilipp Sterzer
Mar 5, 2016·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Barbara Juarez, Ming-Hu Han
Jan 7, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Lisheng DuHymie Anisman
May 26, 2015·Neurobiology of Learning and Memory·Nathaniel J BlancoW Todd Maddox
Jun 25, 2013·Neuroscience and Biobehavioral Reviews·Niki AntypaAlessandro Serretti
May 12, 2011·Neuropharmacology·Francesco PapaleoDaniel R Weinberger
Sep 3, 2013·Biological Psychiatry·Doron GothelfDaniel R Weinberger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

© 2021 Meta ULC. All rights reserved